Joshua Brody - Publications, H-index & Citations

Joshua Brody

icahn school of medicine at mount sinai

44H指数

347论文数

9.8K被引数

收录论文 69

发表时间

Epcoritamab with rituximab and lenalidomide as first-line treatment for follicular lymphoma (EPCORE NHL-2): an open-label, multicentre, phase 1/2 b trial Epcoritamab联合利妥昔单抗和来那度胺作为滤泡性淋巴瘤的一线治疗（EPCORE NHL-2）：一项开放标签、多中心、1/2b期临床试验

Lancet Haematology

IF17.7

2026-08-27

OAAI

Lorenzo Falchi; Joost S P Vermaat; Joshua D Brody; Lori Leslie; Fritz Offner; Jacob Haaber Christensen; Marcel Nijland; David Belada; Björn Engelbrekt Wahlin; Kristina Drott; Pilar Gomez Prieto; Kateřina Kopečkova; Alejandro Martín García-Sancho; Jian P Mei; Işıl Altıntaş; Malene Risum; Aidan Reilly; Jun Zou; Pau Abrisqueta

First-line treatment with epcoritamab in combination with bendamustine plus rituximab induces sustained remissions beyond 3 years in patients with follicular lymphoma 使用epcoritamab联合 bendamustine和rituximab的一线治疗在滤泡性淋巴瘤患者中诱导了超过3年的持续缓解

HemaSphere

IF14.6

2026-08-05

OAAI

Umberto Vitolo; Lorenzo Falchi; Per-Ola Andersson; Marcel Nijland; Fritz Offner; Sylvia Snauwaert; Jacob H. Christensen; Michael R. Clausen; Alexander Fosså; Pilar G. Prieto; Eliza A. Hawkes; Judit M. Jørgensen; Yasmin H. Karimi; Catharina Lewerin; Joost S. P. Vermaat; Björn E. Wahlin; Poliana Patah; Christopher Morehouse; Malene Risum; Zhu Li; Jennifer Marek; Joshua D. Brody

Dendritic cells control tertiary lymphoid structure development and maintenance in cancer 树突状细胞调控肿瘤中三级淋巴样结构的发育与维持

Science

IF45.8

2026-07-16

PREAI

Raphaël Mattiuz; Jesse Boumelha; Emmanouil Aerakis; Jessica Le Berichel; Pauline Hamon; Laszlo Halasz; Abishek Vaidya; Brian Y. Soong; Emir Radkevich; Hye Mi Kim; Matthew D. Park; Romain Donne; Leanna Troncoso; Rachel A. Kaplan; Clotilde Hennequin; Isaias Hernández-Verdin; Lucía López; Frederika Rentzeperis; Darwin D’Souza; Medard Ernest Kaiza; Ian P. MacFawn; Meriem Belabed; Guillaume Mestrallet; Etienne Humblin; Raphaël Merand; Samarth Hegde; Jean-Christophe Lone; Giorgio Ioannou; Sinem Ozbey; Igor Figueiredo; Alexander Tepper; Hajer Merarda; Nadine Serhan; Maximilian M. Schaefer; Jinping An; Ray A. Ohara; Erika Nemeth; Simon Goldstein; Amanda M. Reid; Moataz Noureddine; Alexandra Tabachnikova; Giulia Maria Piperno; Maria Tsoumakidou; Jalal Ahmed; Alexandros D. Polydorides; Nina Bhardwaj; Amaia Lujambio; Zhihong Chen; Edgar Gonzalez Kozlova; Seunghee Kim-Schulze; Joshua D. Brody; Michael Schotsaert; Christine Moussion; Sacha Gnjatic; Vladimir Roudko; Florent Ginhoux; Kenneth M. Murphy; Catherine Sautès-Fridman; Wolf Herman Fridman; Brian D. Brown; Thomas U. Marron; Federica Benvenuti; Jason G. Cyster; Hélène Salmon; Tullia C. Bruno; Nikhil S. Joshi; Alice O. Kamphorst; Miriam Merad

mRNA vaccine immunity is enhanced by hepatocyte detargeting and not dependent on dendritic cell expression mRNA疫苗的免疫力通过肝细胞脱靶增强，且不依赖于树突状细胞表达

Nature Biotechnology

IF41.7

2026-04-29

OAAI

Adam Marks; Sophia Siu; Filippo Bianchini; Chunxi Wang; Ashwitha Lakshmi; Matthew Phelan; Andrew Zhu; Chang Moon; Judit Morla-Folch; Abraham J. P. Teunissen; Angelo Amabile; Alessia Baccarini; Miriam Merad; Joshua D. Brody; Yizhou Dong; Brian D. Brown

Transcriptome sequencing of Hodgkin lymphoma Hodgkin and Reed-Sternberg cells reveals escape from NK cell recognition and an unfolded protein response 霍奇金淋巴瘤霍奇金和里德-斯滕伯格细胞的转录组测序揭示NK细胞识别逃逸和未折叠蛋白反应

Blood Cancer Journal

IF11.6

2026-04-22

OAAI

Mikhail Roshal; Isabella Y. Kong; Wikum Dinalankara; Jonathan B. Reichel; Matthew Teater; Bhavneet Binder; Sakellarios Zairis; Joshua D. Brody; Sunita I. Park; Alexandra E. Kovach; Nitya Gulati; Matthew J. Oberley; Megan S. Lim; Matthew J. Barth; Olivier Elemento; Ari Melnick; Raul Rabadan; Amy Chadburn; Luigi Marchionni; Lisa Giulino-Roth; Ethel Cesarman

Armored macrophage-targeted CAR-T cells reset and reprogram the tumor microenvironment and control metastatic cancer growth 装甲巨噬细胞靶向car-t细胞重置和重编程肿瘤微环境并控制转移性癌症生长

Cancer Cell

IF44.5

2026-01-22

PREAI

Jaime Mateus-Tique; Ashwitha Lakshmi; Bhavya Singh; Rhea Iyer; Alfonso R. Sánchez-Paulete; Chiara Falcomatà; Matthew Lin; Gvantsa Pantsulaia; Alexander Tepper; Trung Nguyen; Angelo Amabile; Gurkan Mollaoglu; Luisanna Pia; Divya Chhamalwan; Jessica Le Berichel; Hunter Potak; Marco Colonna; Alessia Baccarini; Joshua Brody; Miriam Merad

Nivolumab plus brentuximab vedotin for relapsed/refractory diffuse large B-cell lymphoma 纳武利尤单抗联合 Brentuximab Vedotin 治疗复发/难治性弥漫性大B细胞淋巴瘤

Future Oncology

IF2.6

2025-12-10

OAAI

Nathalie A. Johnson; Pier Luigi Zinzani; Eva Domingo-Domenech; Joshua Brody; Justin Kline; Bijal Dinesh Shah; Amitkumar Nitinkumar Mehta; Herve Ghesquieres; Kerry J. Savage; Paul M. Barr; Armando Santoro; Silvia Ferrari; David Cunningham; Graham P. Collins; Michelle Fanale; Jennifer Krajewski; Alev Akyol; Russell Crowe; Rachael Wen; John Kuruvilla

ScSeq of human antigen-escaping tumor variants reveals their plasma-cell-like phenotype

JOURNAL OF IMMUNOLOGY

IF3.4

2025-11-01

PREAI

Odak, Ivan; Riemann, Lennart; Xie, Xinping; Brody, Joshua

Real-world outcomes of patients with aggressive B-cell lymphoma treated with epcoritamab or glofitamab Brooks, T.R.; Zabor, E.C.; Bedelu, Y.; Yang, X.; Karimi, Y.H.; Nedved, A.N.; Wang, Y.; Dave, N.K.; Landsburg, D.J.; Baron, K.; et al. 接受epcoritamab或glofitamab治疗的侵袭性B细胞淋巴瘤患者的真实世界结局。Blood 2025, in press. [Google Scholar] [CrossRef]

Blood

IF23.1

2025-07-17

PREAI

Taylor R. Brooks; Emily C. Zabor; Yohanna B. Bedelu; Xi Yang; Yasmin H. Karimi; Adrienne N. Nedved; Yucai Wang; Nikita Dave; Daniel J. Landsburg; Kelsey Baron; Boyu Hu; Daniel C. Trotier; Priyanka A. Pophali; Jordan Miller; Natalie Grover; Catherine Reinert; Ajay Major; Tenley Schwarz; Krish Patel; Kiarash Salafian; Emily Ayers; Suchitra Sundaram; Joshua D. Brody; Marshall McKenna; Yun Kyoung Ryu Tiger; Megan Sears-Smith; Nilanjan Ghosh; Chelsea Peterson; Cyrus Khan; Sean P. Bliven; Mayur Narkhede; Alyssa Gibson; Justin Kline; Javier Munoz; Rodolfo Garza-Morales; Carrie I. Ho; Stephen D. Smith; Alex Niu; Francisco Hernandez-Ilizaliturri; Fadzai Chinyengetere; Sandeep Dave; Nayef Abdel-Razeq; Muhamad Alhaj Moustafa; Paolo F. Caimi; Brian T. Hill

Cancer vaccines and the future of immunotherapy 癌症疫苗与免疫疗法的未来

lancet

IF0

2025-06-18

PREAI

Orrin Pail; Matthew J Lin; Theodora Anagnostou; Brian D Brown; Joshua D Brody

Epcoritamab plus GemOx in transplant-ineligible relapsed/refractory DLBCL: results from the EPCORE NHL-2 trial Epcoritamab联合GemOx在移植不合格的复发/难治性DLBCL中的应用：EPCORE NHL-2试验的结果

BLOOD

IF23.1

2025-01-10

OAAI

Brody, Joshua D.; Jorgensen, Judit; Belada, David; Costello, Regis; Trneny, Marek; Vitolo, Umberto; Lewis, David John; Karimi, Yasmin H.; Sureda, Anna; Andre, Marc; Wahlin, Bjoern E.; Lugtenburg, Pieternella J.; Jiang, Tony; Karagoz, Kubra; Steele, Andrew J.; Abbas, Aqeel; Wang, Liwei; Risum, Malene; Cordoba, Raul

Dexamethasone is associated with reduced frequency and intensity of cytokine release syndrome compared with alternative corticosteroid regimens as premedication for glofitamab inpatients with relapsed/refractory large B-cell lymphoma 地塞米松与 glofitamab 预治疗中替代糖皮质激素方案相比，可降低大B细胞淋巴瘤复发/难治性患者细胞因子释放综合征的发生频率和强度。

HAEMATOLOGICA

IF7.9

2024-11-28

OAAI

Falchi, Lorenzo; Hutchings, Martin; Carlo-Stella, Carmelo; Morschhauser, Franck; Dickinson, Michael; Cartron, Guillaume; Khan, Cyrus; Tani, Monica; Martinez-Lopez, Joaquin; Bartlett, Nancy L.; Salar, Antonio; Brody, Joshua D.; Berthier, Aurelien; Kallemeijn, Martine; Relf, James; Tchaleu, Fabiola Bene; Lundberg, Linda; Bachy, Emmanuel

Real-World Outcomes with Bispecific T-Cell Engagers (REALBiTE) for Relapsed or Refractory Large B-Cell Lymphoma: A Multi-Center, Retrospective Cohort Study 真实世界中使用双特异性T细胞衔接器（REALBiTE）治疗复发或难治性大B细胞淋巴瘤的结局：一项多中心、回顾性队列研究

BLOOD

IF23.1

2024-11-05

PREAI

Brooks, Taylor R.; Zabor, Emily C.; Bedelu, Yohana B.; Dave, Nikita; Landsburg, Daniel J.; Nedved, Adrienne N.; Wang, Yucai; Reinert, Catherine; Major, Ajay; Sears-Smith, Megan; Ghosh, Nilanjan; Salafian, Kiarash; Ayers, Emily; Miller, Jordan; Grover, Natalie; Peterson, Chelsea; Khan, Cyrus; Bliven, Sean Patrick; Narkhede, Mayur S.; Ho, Carrie, I; Smith, Stephen D.; Gibson, Alyssa; Kline, Justin; Sundaram, Suchitra; Brody, Joshua; Baron, Kelsey; Hu, Boyu; Trotier, Daniel; Pophali, Priyanka A.; Yang, Xi; Karimi, Yasmin H.; Mckenna, Marshall; Tiger, Yun Kyoung; Niu, Alex; Hernandez-Ilizaliturri, Francisco; Morales, Rodolfo Garza; Munoz, Javier; Chinyengetere, Fadzai; Dave, Sandeep; Abdel-Razeq, Nayef; Moustafa, Muhamad Alhaj; Caimi, Paolo F.; Hill, Brian T.

Demystifying the Delivery and Adverse Event Management of Bispecific Antibodies in the Community Setting 揭秘双特异性抗体在社区环境中的递送和不良事件管理

BLOOD

IF23.1

2024-11-05

PREAI

Hodzic, Rifeta Kajdic; Mehta, Amitkumar N.; Koff, Jean L.; Budde, Elizabeth; Devarakonda, Srinivas; Moore, Donald C.; Brody, Joshua; Wuthrich, Bradley; Mancini, Robert; Martin, Cassie; Mangir, Christina; Harvey, Allison; Plotkin, Elana; Kisiel, Molly; Lile, Ashley; Colwell, Nicole A.

End points in clinical trials in diffuse large B-cell lymphoma: time for more dialogue?弥漫性大b细胞淋巴瘤临床试验的终点: 是时候进行更多对话了？

FUTURE ONCOLOGY

IF2.6

2024-06-18

OAAI

Degtyarev, Evgeny; Bolanos, Natacha; Brody, Joshua D.; Buchbinder, Aby; Buyse, Marc; Fuchs, Miriam; Halabi, Susan; Hemmings, Robert; Masood, Aisha; Newsome, Simon; Saxton, Claire; Warwick, Lorna; Yateman, Nigel A.; Zuber, Emmanuel

Nivolumab plus brentuximab vedotin for relapsed/refractory peripheral T-cell lymphoma and cutaneous T-cell lymphoma Nivolumab联合brentuximab vedotin治疗复发/难治性外周T细胞淋巴瘤和皮肤T细胞淋巴瘤

BLOOD ADVANCES

IF7.1

2024-05-20

OAAI

Zinzani, Pier Luigi; Salles, Gilles; Moskowitz, Alison J.; Santoro, Armando; Mehta, Amitkumar; Barr, Paul M.; Mehta-Shah, Neha; Collins, Graham P.; Ansell, Stephen M.; Brody, Joshua D.; Domingo-Domenech, Eva; Johnson, Nathalie A.; Cunningham, David; Ferrari, Silvia; Lisano, Julie; Krajewski, Jennifer; Wen, Rachael; Akyol, Alev; Crowe, Russell; Savage, Kerry J.

Immunotherapy-resistant acute lymphoblastic leukemia cells exhibit reduced CD19 and CD22 expression and BTK pathway dependency

JOURNAL OF CLINICAL INVESTIGATION

IF13.6

2024-02-20

OAAI

Aminov, Sarah; Giricz, Orsi; Melnekoff, David T.; Sica, R. Alejandro; Polishchuk, Veronika; Papazoglu, Cristian; Yates, Bonnie; Wang, Hao-Wei; Sahu, Srabani; Wang, Yanhua; Gordon-Mitchell, Shanisha; Leshchenko, Violetta V.; Schinke, Carolina; Pradhan, Kith; Aluri, Srinivas; Sohn, Moah; Barta, Stefan K.; Agarwal, Beamon; Goldfinger, Mendel; Mantzaris, Ioannis; Shastri, Aditi; Matsui, William; Steidl, Ulrich; Brody, Joshua D.; Shah, Nirali N.; Parekh, Samir; Verma, Amit

Phase I Study of GS-3583, an FMS-like Tyrosine Kinase 3 Agonist Fc Fusion Protein, in Patients with Advanced Solid Tumors

CLINICAL CANCER RESEARCH

IF10.2

2024-01-31

OAAI

Tolcher, Anthony W.; Brody, Joshua D.; Rajakumaraswamy, Nishanthan; Kuhne, Michelle; Trowe, Torsten; Dauki, Anees M.; Pai, Shantheri; Han, Ling; Lin, Kai-Wen; Petrarca, Michael; Kummar, Shivaani

Brentuximab vedotin as a bridge to combination chemotherapy in gray zone lymphoma with severe liver impairment: a case report

FRONTIERS IN ONCOLOGY

IF3.3

2024-01-19

OAAI

Asrani, Roshan; Cengiz, Turgot Bora; Petersen, Bruce E.; Anagnostou, Theodora; Brody, Joshua D.

Pattern recognition receptor agonists in pathogen vaccines mediate antitumor T-cell cross-priming 病原体疫苗中的模式识别受体激动剂介导抗肿瘤T细胞交叉引发

JOURNAL FOR IMMUNOTHERAPY OF CANCER

IF10.6

2023-07-24

OAAI

Aleynick, Mark; Svensson-Arvelund, Judit; Pantsulaia, Gvantsa; Kim, Kristy; Rose, Samuel A.; Upadhyay, Ranjan; Yellin, Michael; Marsh, Henry; Oreper, Daniel; Jhunjhunwala, Suchit; Moussion, Christine Carine; Merad, Miriam; Brown, Brian D.; Brody, Joshua D.

研究方向